News

August 2017

Our work with Prof. Lohitash at UGA is in the news.


GT-Bionics Lab will participate in the IEEE BioCAS 2017 with 5 papers.


Congratulations to Prof. Byunghun Lee for his new position; Assistant Professor at Incheon University in Korea.


July 2017

GT-Bionics receives funding from the NSF to study the thermal management of wirelessly-powered implantable devices


March 2017

Byunghun successfully defended his thesis and graduated from GT-Bionics as a PhD student. Congratulations, Dr. Byunghun Lee!


Congratulation to Daniel Canales for receiving the ECE Undergraduate Research Award!


Jaemyung successfully defended his thesis and graduated from GT-Bionics as a PhD student. Congratulations, Dr. Jaemyung Lim!


February 2017

Dr. Ghovanloo has been awarded promotion to Full Professor. Congratulations! Please see the story here.


September 2016

GT just released story about our EnerCage project!


Dr. Ghovanloo will give a talk on 8th Seminar on Electronics and Advanced Design with title "Implantable and wearable microelectronic device to improve quality of life for people with disabilities".


August 2016

We have two papers at EMBC'16.


Temi successfully defended her thesis and graduated from GT-Bionics as a PhD student. Congratulations, Dr. Temi Prioleau!


June 2016

Temi received Chi Foundation award. Congratulations Temi!


Pharmaceutical Compliance
Monitoring System

Patients forget to take their medicine, they may think side effects outweigh benefits, they may not believe the diagnosis, they may not understand the directions correctly, they may not know enough about the side-effects, they may use too much, or they may view the medicine as too costly. For whatever reason, even the best medications cannot cure diseases if the patients do not take them in the right doses at the right time. The topic of “pharmaceutical compliance” has become a key issue due to increasing difficulties in achieving point-of-differentiation and health economic objectives justifying premium pricing and reimbursement. We are working on a novel drug compliance monitoring device suitable for clinical and pharmaceutical trials. It can also be an integrated part of the marketed drug concepts.